Kerecis AG

Suisse

Retour au propriétaire
1-13 de 13 pour Kerecis AG Trier par
Recheche Texte
Affiner par
Type PI
        Marque 9
        Brevet 4
Juridiction
        États-Unis 5
        Canada 4
        International 4
Date
2021 3
2020 8
Avant 2020 1
Classe IPC
A61K 36/38 - Clusiaceae, Hypericaceae ou Guttiferae (famille de l'Hypericum ou du mangoustan), p. ex. millepertuis 4
A61K 36/58 - Meliaceae (famille du margousier ou de l'acajou), p. ex. margosa (neem) 4
A61K 31/155 - Amidines (), p. ex. guanidine (H2N-C(=NH)-NH2), isourée (HN=C(OH)NH2), isothiourée (HN=C(SH)-NH2) 2
A61K 31/731 - Carraghénanes 2
A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier 2
Voir plus
Statut
En Instance 1
Enregistré / En vigueur 12

1.

ANTIMICROBIAL SOLUTIONS AND METHODS OF USING THE SAME IN THE TREATMENT OR PREVENTION OF INFECTIONS

      
Numéro d'application IB2021052408
Numéro de publication 2021/191800
Statut Délivré - en vigueur
Date de dépôt 2021-03-23
Date de publication 2021-09-30
Propriétaire KERECIS AG (Suisse)
Inventeur(s)
  • Sigurjonsson, Gudmundur Fertram
  • Gisladottir, Dora Hlin
  • Kristjansson, Jon Magnus

Abrégé

Hypericum spp.Hypericum spp., polyunsaturated fatty acids (PUFAs), carrageenans, and/or chlorhexidine; and (optionally) in combination with one or more pharmaceutically acceptable carriers, additives, and/or diluents. The antimicrobial compositions are effective in treating or preventing upper respiratory tract infections, preferably upper respiratory tract infections caused by human Coronaviruses and are included within methods of treating or preventing infection of the upper respiratory tract of humans by a microbial pathogen.

Classes IPC  ?

  • A61K 36/38 - Clusiaceae, Hypericaceae ou Guttiferae (famille de l'Hypericum ou du mangoustan), p. ex. millepertuis
  • A61K 36/58 - Meliaceae (famille du margousier ou de l'acajou), p. ex. margosa (neem)
  • A61K 31/155 - Amidines (), p. ex. guanidine (H2N-C(=NH)-NH2), isourée (HN=C(OH)NH2), isothiourée (HN=C(SH)-NH2)
  • A61K 31/731 - Carraghénanes
  • A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
  • A61K 9/10 - DispersionsÉmulsions
  • A61P 31/00 - Agents anti-infectieux, c.-à-d. antibiotiques, antiseptiques, chimiothérapeutiques
  • A61P 31/14 - Antiviraux pour le traitement des virus ARN

2.

Antimicrobial solutions and methods of using the same in the treatment or prevention of infections

      
Numéro d'application 17209807
Numéro de brevet 12478583
Statut Délivré - en vigueur
Date de dépôt 2021-03-23
Date de la première publication 2021-09-23
Date d'octroi 2025-11-25
Propriétaire KERECIS AG (Suisse)
Inventeur(s)
  • Sigurjonsson, Gudmundur Fertram
  • Gisladottir, Dora Hlin
  • Kristjansson, Jon Magnus

Abrégé

Hypericum spp., polyunsaturated fatty acids (PUFAs), carrageenans, and/or chlorhexidine; and (optionally) in combination with one or more pharmaceutically acceptable carriers, additives, and/or diluents. The antimicrobial compositions are effective in treating or preventing upper respiratory tract infections, preferably upper respiratory tract infections caused by human Coronaviruses and are included within methods of treating or preventing infection of the upper respiratory tract of humans by a microbial pathogen.

Classes IPC  ?

  • A61K 9/08 - Solutions
  • A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
  • A61K 31/122 - Cétones ayant l'atome d'oxygène lié directement à un cycle, p. ex. quinones, vitamine K1, anthraline
  • A61K 31/155 - Amidines (), p. ex. guanidine (H2N-C(=NH)-NH2), isourée (HN=C(OH)NH2), isothiourée (HN=C(SH)-NH2)
  • A61K 31/731 - Carraghénanes
  • A61K 36/38 - Clusiaceae, Hypericaceae ou Guttiferae (famille de l'Hypericum ou du mangoustan), p. ex. millepertuis
  • A61K 36/58 - Meliaceae (famille du margousier ou de l'acajou), p. ex. margosa (neem)
  • A61K 47/10 - AlcoolsPhénolsLeurs sels, p. ex. glycérolPolyéthylène glycols [PEG]PoloxamèresAlkyléthers de PEG/POE

3.

VIRUXAL

      
Numéro d'application 1575964
Statut Enregistrée
Date de dépôt 2020-09-30
Date d'enregistrement 2020-09-30
Propriétaire Kerecis AG (Suisse)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for skin wounds; antimicrobial preparations for preventing infectious disease in humans; pharmaceutical products for the prevention or treatment of microbial diseases in humans; antimicrobial preparations for treating or alleviating symptomatic infections in humans; cold and flu treatment preparations; antimicrobial preparations containing plant extracts and fish oils; antimicrobial preparations containing neem oil, hypericum extracts and fish-derived polyunsaturated fatty acids.

4.

VIRUXORAL

      
Numéro d'application 1563601
Statut Enregistrée
Date de dépôt 2020-10-23
Date d'enregistrement 2020-10-23
Propriétaire Kerecis AG (Suisse)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for skin wounds; antimicrobial preparations for preventing infectious disease in humans; pharmaceutical products for the prevention or treatment of microbial diseases in humans; antimicrobial preparations for treating or alleviating symptomatic infections in humans; cold and flu symptom treatment preparations; antimicrobial preparations containing plant extracts and fish oils for preventing viruses; antimicrobial preparations containing neem oil, Hypericum extracts, and fish-derived polyunsaturated fatty acids for preventing viruses.

5.

VIRUXNASAL

      
Numéro d'application 1563718
Statut Enregistrée
Date de dépôt 2020-10-23
Date d'enregistrement 2020-10-23
Propriétaire Kerecis AG (Suisse)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for skin wounds; antimicrobial preparations for preventing infectious disease in humans; pharmaceutical products for the prevention or treatment of microbial diseases in humans; antimicrobial preparations for treating or alleviating symptomatic infections in humans; cold and flu symptom treatment preparations; antimicrobial preparations containing plant extracts and fish oils for preventing viruses; antimicrobial preparations containing neem oil, hypericum extracts, and fish-derived polyunsaturated fatty acids for preventing viruses.

6.

VIRUXORAL

      
Numéro d'application 206811300
Statut Enregistrée
Date de dépôt 2020-10-23
Date d'enregistrement 2023-12-04
Propriétaire Kerecis AG (Suisse)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations for skin wounds, namely pharmaceutical preparations for the prevention or treatment of bacterial skin infections, fungal skin infections, viral skin infections, parasitic skin infections, diabetic ulcers, arterial ulcers, venous ulcers, leg ulcers, foot ulcers, scars, skin abscesses, parchment skin, pilonidal sinus, and suture dehiscence; pharmaceutical preparations for skin wounds, namely pharmaceutical preparations for burns, thermal burns, and chemical burns; pharmaceutical preparations for wounds; pharmaceutical products for the prevention and treatment of microbial diseases in humans; cold and flu symptom treatment preparations; antimicrobial preparations containing fish oils for preventing viruses; antimicrobial preparations containing neem oil, Hypericum extracts, and fish-derived polyunsaturated fatty acids for preventing viruses.

7.

VIRUXNASAL

      
Numéro d'application 206811600
Statut Enregistrée
Date de dépôt 2020-10-23
Date d'enregistrement 2023-10-11
Propriétaire Kerecis AG (Suisse)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations for skin wounds, namely pharmaceutical preparations for the prevention or treatment of bacterial skin infections, fungal skin infections, viral skin infections, parasitic skin infections, diabetic ulcers, arterial ulcers, venous ulcers, leg ulcers, foot ulcers, scars, skin abscesses, parchment skin, pilonidal sinus, and suture dehiscence; pharmaceutical preparations for skin wounds, namely pharmaceutical preparations for burns, thermal burns, and chemical burns; pharmaceutical preparations for wounds; pharmaceutical products for the prevention or treatment of microbial diseases in humans; antimicrobial preparations for dermatologic use; cold and flu symptom treatment preparations; antimicrobial preparations containing fish oils for preventing viruses; antimicrobial preparations containing neem oil, Hypericum extracts, and fish-derived polyunsaturated fatty acids for preventing viruses.

8.

VIRUXORAL

      
Numéro de série 90232238
Statut Enregistrée
Date de dépôt 2020-10-02
Date d'enregistrement 2023-04-04
Propriétaire Kerecis AG (Suisse)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for skin wounds; Antimicrobial preparations for preventing infectious disease in humans; Pharmaceutical products for the prevention and treatment of microbial diseases in humans; Antimicrobial preparations for treating and alleviating symptomatic infections in humans; Cold and flu symptom treatment preparations; Antimicrobial preparations containing plant extracts and fish oils for preventing viruses; Antimicrobial preparations containing neem oil, Hypericum extracts, and fish-derived polyunsaturated fatty acids for preventing viruses

9.

VIRUXNASAL

      
Numéro de série 90232255
Statut Enregistrée
Date de dépôt 2020-10-02
Date d'enregistrement 2023-04-04
Propriétaire Kerecis AG (Suisse)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for skin wounds; Antimicrobial preparations for preventing infectious disease in humans; Pharmaceutical products for the prevention and treatment of microbial diseases in humans; Antimicrobial preparations for treating and alleviating symptomatic infections in humans; Cold and flu symptom treatment preparations; Antimicrobial preparations containing plant extracts and fish oils for preventing viruses; Antimicrobial preparations containing neem oil, Hypericum extracts, and fish-derived polyunsaturated fatty acids for preventing viruses

10.

VIRUXAL

      
Numéro d'application 208529900
Statut Enregistrée
Date de dépôt 2020-09-30
Date d'enregistrement 2023-10-11
Propriétaire Kerecis AG (Suisse)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations for skin wounds, namely pharmaceutical preparations for the prevention or treatment of bacterial skin infections, fungal skin infections, viral skin infections, parasitic skin infections, diabetic ulcers, arterial ulcers, venous ulcers, leg ulcers, foot ulcers, scars, skin abscesses, parchment skin, pilonidal sinus, and suture dehiscence; pharmaceutical preparations for skin wounds, namely pharmaceutical preparations for burns, thermal burns, and chemical burns; pharmaceutical preparations for wounds; antimicrobial preparations for dermatologic use; pharmaceutical products for the prevention or treatment of microbial diseases in humans; cold and flu symptom treatment preparations; antimicrobial preparations containing fish oils for preventing viruses; antimicrobial preparations containing neem oil, Hypericum extracts, and fish-derived polyunsaturated fatty acids for preventing viruses.

11.

VIRUXAL

      
Numéro de série 88854050
Statut Enregistrée
Date de dépôt 2020-03-31
Date d'enregistrement 2023-06-27
Propriétaire KERECIS AG (Suisse)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for skin wounds; Antimicrobial preparations for preventing infectious disease in humans; Pharmaceutical products for the prevention or treatment of microbial diseases in humans; Antimicrobial preparations for treating or alleviating symptomatic infections in humans; Cold and flu symptom treatment preparations; Antimicrobial preparations containing plant extracts and fish oils for the prevention or treatment of microbial diseases or symptomatic infections in humans; Antimicrobial preparations containing neem oil, Hypericum extracts, and fish-derived polyunsaturated fatty acids for the prevention or treatment of microbial diseases or symptomatic infections in humans

12.

Composition comprising natural substances having healing, repellent and biocidal properties for the treatment and the cure of external wounds

      
Numéro d'application 11659028
Numéro de brevet 10293011
Statut Délivré - en vigueur
Date de dépôt 2005-07-29
Date de la première publication 2008-12-11
Date d'octroi 2019-05-21
Propriétaire KERECIS AG (Suisse)
Inventeur(s)
  • Carnevali, Fiorella
  • Van Der Esch, Stephen Andrew

Abrégé

Hypericum. The compositions have healing, anti-bacterial, anti-inflammatory, and pain relieving properties combined with a repellent effect against myiasigenic diptera and non-myiasigenic diptera. The compositions can be used for the treatment and the cure of external wounds of any type and extension.

Classes IPC  ?

  • A61K 36/53 - Lamiaceae ou Labiatae (famille de la menthe), p. ex. thym, romarin ou lavande
  • A61K 36/38 - Clusiaceae, Hypericaceae ou Guttiferae (famille de l'Hypericum ou du mangoustan), p. ex. millepertuis
  • A61K 36/58 - Meliaceae (famille du margousier ou de l'acajou), p. ex. margosa (neem)

13.

ANTIMICROBIAL SOLUTIONS AND METHODS OF USING THE SAME IN THE TREATMENT OR PREVENTION OF INFECTIONS

      
Numéro de document 03170227
Statut En instance
Date de dépôt 2021-03-23
Propriétaire KERECIS AG (Suisse)
Inventeur(s)
  • Sigurjonsson, Gudmundur Fertram
  • Gisladottir, Dora Hlin

Abrégé

Antimicrobial compositions include a therapeutically effective amount of neem oil, extract of the plant Hypericum spp., polyunsaturated fatty acids (PUFAs), carrageenans, and/or chlorhexidine; and (optionally) in combination with one or more pharmaceutically acceptable carriers, additives, and/or diluents. The antimicrobial compositions are effective in treating or preventing upper respiratory tract infections, preferably upper respiratory tract infections caused by human Coronaviruses and are included within methods of treating or preventing infection of the upper respiratory tract of humans by a microbial pathogen.

Classes IPC  ?

  • A61K 36/38 - Clusiaceae, Hypericaceae ou Guttiferae (famille de l'Hypericum ou du mangoustan), p. ex. millepertuis
  • A61K 36/58 - Meliaceae (famille du margousier ou de l'acajou), p. ex. margosa (neem)
  • A61P 31/14 - Antiviraux pour le traitement des virus ARN